COMP <GO>
PM vs MRK // PIOTROSKI F-SCORE QUALITY
Philip Morris International Inc (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: PM 7
— MRK 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: PM
LAST: $208.79 (+0.14%) • MKT CAP: $324.98B
piotroski-score
8/9
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PM VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PM | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.10% | 74.80% | -7.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 45.30% | 20.70% | +24.60 | PM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.7x | 15.3x | +6.40 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.28% | 3.42% | -0.14 | MRK | /fcf-yield <GO> |
| Operating Margin | 36.60% | 34.30% | +2.30 | PM | /operating-margins <GO> |
| Net Profit Margin | 27.90% | 28.10% | -0.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 7.30% | 1.30% | +6.00 | PM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.65% | 2.26% | +0.39 | PM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.52 | 5.19 | -0.67 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 7/9 | +1.00 | PM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.60% | +0.10 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.5 | 56.9 | +7.63 | PM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.92 | +0.01 | PM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.6x | 18.4x | +8.20 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $324.98B | $361.02B | -$36.04B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PM REV | MRK REV | PM GROSS % | MRK GROSS % | PM FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.65B | $65.01B | 67.1% | 74.8% | $10.66B | $12.36B |
| FY 2024 | $37.88B | $64.17B | 64.8% | 76.3% | $10.77B | $18.10B |
| FY 2023 | $35.17B | $60.12B | 44.0% | 44.0% | $7.62B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PM // BETA 0.93
MRK // BETA 0.92